Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
(Q39771144)
scientific article
scientific article
Language:
Current Data About
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
other details
description | scientific article |
External Links
(P356) |
10.1038/ONC.2009.403
|
(P698) |
19935717
|
(P932) |
2908017
|
(P5875) |
40029020
|
(P6179) |
1014096766
|